|
|
![]() ![]() |
|
Cerebrovascular Complications
Literature has documented that strokes and transient ischemic attacks are associated with Fabry disease.[1,2] Thrombosis of small arteries thickened by the vascular accumulation of GL-3 lipids makes Fabry patients vulnerable to early ischemic stroke.[3] Thrombus formation may also be enhanced in Fabry disease due to adhesion of neutrophils and monocytes to endothelial cell walls.[4] Hypertension associated with renal dysfunction may also increase the risk for hemorrhagic stroke.[3] Other Fabry-related cerebrovascular signs and symptoms associated with Fabry disease may include:[1]
For a list of articles related to cardiovascular complications associated with Fabry disease, click here. References 1. Desnick RJ, Ioannou YA, Eng CM. Alpha-galactosidase A deficiency: Fabry disease. In: The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw Hill, 2001;3733-3774. 2. Grewal RP. Stroke in Fabry’s disease. J Neurol 1994;241:153-156. 3. Grewal RP, McLatchey SK. Cerebrovascular manifestations in a female carrier of Fabry’s disease. Acta Neurol Belg. 1992;92:36-40. 4. DeGraba T, Azhar S, Dignat-George F, et al. Profile of endothelial and leukocyte activation in Fabry patients. Ann Neurol. 2000;47:229-233. |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Terms and Conditions of Use | Privacy Policy | © 2003-2009 Genzyme Corporation. All rights reserved.| © Fabr/US/P219/08/05 |
|